Navigation Links
The NeoStrata Company Appoints a New Vice President of Operations
Date:9/17/2007

PRINCETON, N.J., Sept. 17 /PRNewswire/ -- The NeoStrata Company, Inc. announced today the appointment of Peter Crisafulli to the position of Vice President of Operations. In his new role, Mr. Crisafulli will support the continued growth of NeoStrata's existing brands, both domestically and in more than 70 countries around the world.

"I'm thrilled to be joining the wonderful people of NeoStrata at this exciting time in the company's life," said Mr. Crisafulli, "I look forward to helping them meet all their growth needs across all their markets."

Mr. Crisafulli joins The NeoStrata Company, Inc. with many years of senior management experience in the pharmaceutical and personal care industries. Most recently, he had been consulting for Johnson & Johnson. Previously, he spent fourteen years in ever increasing operation positions at Revlon rising to be their Vice President of International Operations. His prior experience also includes sixteen years with Ciba-Geigy, including time as their Vice President of Manufacturing. Mr. Crisafulli brings a strong track record of manufacturing and operational excellence which should truly help facilitate NeoStrata's domestic and international growth.

Mr. Crisafulli holds a B.S. degree in Industrial Engineering from the New Jersey Institute of Technology, and an MBA from Seton Hall University.

About The NeoStrata Company, Inc.

The NeoStrata Company is a privately held, research-based company located in Princeton, New Jersey. It was founded in 1988 by leading dermatological researchers and inventors, Ruey J.Yu, Ph.D., O.M.D., and dermatologist Eugene J. Van Scott, M.D., who are widely recognized as the pioneers of alpha-hydroxy acid (AHA) technology. Today, NeoStrata continues to develop and to license its extensive portfolio of patented technology including polyhydroxy acids (PHAs) and the bionic acids, as well as novel N-acetyl amino sugars and N-acetyl amino acids for cosmetic, OTC and Rx applications. NeoStrata also markets globally its own comprehensive lines of skincare brands, including NeoStrata, Exuviance and CoverBlend; and, has recently initiated its first clinical studies for prescription dermatologicals.


'/>"/>
SOURCE The NeoStrata Company, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medicis Pharmaceutical company enters pediatric market
2. Problems Of a Growing Company
3. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
4. British company developing ‘Safer Cigarettes
5. Australian Company Gets $10 million For Developing Skin Cancer Gel
6. Elderly People Prefer The Company Of Pet Dogs
7. Ossur Acquires the U.S. Orthopaedics Company
8. Britain Approves Indian Company For Supplying Medicines
9. Drug Company Admits Knowledge Of Side Effects In Monkeys
10. Ranbaxy Expands By Acquiring A Generic Company In Belgium
11. Indian Training Company To Train Children In Dubai, Sharjah
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... Coppin Insurance ... owners and families in and around the Cape Coral area, is embarking on a ... Food Bank of Southwest Florida. , The Harry Chapin Food Bank of Southwest Florida ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a locally owned ... clients in the northern Alabama and Georgia regions, is embarking on a charity ... Works has built a network of support and education facilities to develop and ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... DrugDev ... the announcement that it is one of the early adopters completing EU-U.S. Privacy Shield ... is designed to provide companies on both sides of the Atlantic with a mechanism ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Today, MHA and mental ... mental health systems reform legislation in more than fifty years. We applaud the ... of our elected officials to improving mental health services and supports in our ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children ... bodies, a researcher at the Icahn School of Medicine at Mount Sinai has ... found that when young children are exposed to secondhand marijuana smoke, measurable amounts ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: